Evidence map›Paper›PMID 12531867›Full record

ReviewThe Journal of clinical investigation2003

Programmed cell death in amyotrophic lateral sclerosis.

Christelle Guégan, Serge Przedborski

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Early Golgi Abnormalities and Neurodegeneration upon Loss of Presynaptic Proteins Munc18-1, Syntaxin-1, or SNAP-25.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Multidisciplinary Interventions in Motor Neuron Disease.Journal of neurodegenerative diseases · 2014
    Review
  19. Article
  20. The complex molecular biology of amyotrophic lateral sclerosis (ALS).Progress in molecular biology and translational science · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christelle GuéganDepartment of Neurology, Columbia University, New York, New York, USA.
Serge Przedborski

Funding

TRANSLATIONAL APPROACHES TO NEUROPROTECTION OF AXONS IN PDrP50NS038370 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BURKE, ROBERT E · 1999 to 2014
$24.0M
Proinflammatory enzymes in amytrophic lateral sclerosisR01NS042269 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRZEDBORSKI, SERGE E · 2001 to 2012
$3.0M
SYNUCLEIN AND NIGRAL DOPAMINERGIC NEURON DEGENERATIONR01NS038586 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRZEDBORSKI, SERGE E · 1999 to 2003
$1.3M
NITRIC OXIDE AND PROTEIN NITROTYROSINE IN THE MPTP MODELR29NS037345 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRZEDBORSKI, SERGE E · 1998 to 2002
$358k
NINDS NIH HHS NS42269NINDS NIH HHS P50 NS038370NINDS NIH HHS P50 NS38370NINDS NIH HHS R01 NS038586NINDS NIH HHS R01 NS042269NINDS NIH HHS R01 NS38586NINDS NIH HHS R29 NS37345
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ApoptosisAmyotrophic Lateral SclerosisAnimalsCaspasesDisease Models, AnimalMiceMice, TransgenicMotor NeuronsMutationProto-Oncogene Proteins c-bcl-2Superoxide DismutaseSuperoxide Dismutase-1CaspasesProto-Oncogene Proteins c-bcl-2Sod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID12531867
PMCPMC151885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.